Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04092023
What this trial is testing

Self-care Management Programme for Type 2 Adult DM Patients With Poor Glycemic Control

Who this might be right for
Type 2 Diabetes
Chinese University of Hong Kong 200
Not applicableStudy completedNCT00697450
What this trial is testing

Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 206
Post-approval studies (Phase 4)Study completedNCT02914691
What this trial is testing

Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Peter Rossing 40
Testing effectiveness (Phase 2)Study completedNCT00464880
What this trial is testing

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2
Novartis 24
Post-approval studies (Phase 4)UnknownNCT04340908
What this trial is testing

Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery

Who this might be right for
Diabetes Mellitus, Type 2Cardiac Surgery
Hongchang Guo 500
Early research (Phase 1)Study completedNCT01620424
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 10
Very early researchActive Not RecruitingNCT06826547
What this trial is testing

Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations and the Carbohydrate Fasting Test & Metabolic and Inflammatory Consequences

Who this might be right for
Diabetes Mellitus, Type 2 Treated With InsulinFasting, IntermittentRamadan Fasting+1 more
University Tunis El Manar 100
Large-scale testing (Phase 3)Study completedNCT05369793
What this trial is testing

Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy

Who this might be right for
Type 2 Diabetes (Adult Onset)Diabetic Neuropathies
Tanta University 60
Large-scale testing (Phase 3)Study completedNCT00147758
What this trial is testing

WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Daiichi Sankyo 400
Early research (Phase 1)Study completedNCT01394055
What this trial is testing

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

Who this might be right for
Diabetes Mellitus Type 1 and 2Diabetes Mellitus ComplicationsGastroparesis+1 more
Motus Therapeutics, Inc. 20
Post-approval studies (Phase 4)Study completedNCT00941148
What this trial is testing

Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin

Who this might be right for
Type 2 Diabetic PatientsInsufficient Metabolic ControlOAD Treatment
ikfe-CRO GmbH 30
Not applicableStudy completedNCT02770235
What this trial is testing

Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentErectile Dysfunction
Centre Hospitalier Universitaire, Amiens 97
Not applicableStudy completedNCT01624116
What this trial is testing

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

Who this might be right for
Diabetes, Type 2
Services Hospital, Lahore 161
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Post-approval studies (Phase 4)Study completedNCT00663884
What this trial is testing

Glufast On Insulin Glargine Trial in Type 2 DM

Who this might be right for
Diabetes Mellitus, Type 2
JW Pharmaceutical 167
Large-scale testing (Phase 3)Study completedNCT00622284
What this trial is testing

Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,560
Testing effectiveness (Phase 2)Study completedNCT00811889
What this trial is testing

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 DiabetesDiabetic Nephropathy
Biogen 227
Testing effectiveness (Phase 2)Study completedNCT00542009
What this trial is testing

A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

Who this might be right for
Weight ManagementTreatment Of Obesity
Pfizer 252
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Testing effectiveness (Phase 2)Study completedNCT01068860
What this trial is testing

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Who this might be right for
Type 2 Diabetes MellitusImpaired Glucose Tolerance
Novartis 246
Next Page